US20060089687A1 - System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs - Google Patents
System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs Download PDFInfo
- Publication number
- US20060089687A1 US20060089687A1 US11/272,994 US27299405A US2006089687A1 US 20060089687 A1 US20060089687 A1 US 20060089687A1 US 27299405 A US27299405 A US 27299405A US 2006089687 A1 US2006089687 A1 US 2006089687A1
- Authority
- US
- United States
- Prior art keywords
- light
- area
- sub
- tissue
- light emitting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000019612 pigmentation Effects 0.000 title claims description 14
- 238000001126 phototherapy Methods 0.000 title description 3
- 238000011282 treatment Methods 0.000 claims abstract description 41
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 14
- 230000036564 melanin content Effects 0.000 claims description 3
- 238000009827 uniform distribution Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 53
- 239000000835 fiber Substances 0.000 description 25
- 239000000049 pigment Substances 0.000 description 25
- 208000012641 Pigmentation disease Diseases 0.000 description 12
- 230000003061 melanogenesis Effects 0.000 description 12
- 238000003491 array Methods 0.000 description 9
- 230000002950 deficient Effects 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 238000001720 action spectrum Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000003101 melanogenic effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940027041 8-mop Drugs 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 206010057041 Poikiloderma Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000025600 response to UV Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0614—Tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
Definitions
- the present invention provides for spatially selective phototherapy using LEDs.
- a number of diseases, medical or trauma conditions give rise to cosmetically undesirable pigmentary variation in human skin.
- Scars, temporary or permanent hypo- and hyper-pigmentation, striae (stretch marks), leukoderma, poikiloderma of Civatte, etc. are examples of conditions in which a melanin pigmentation cosmetic defect is presented by at least one component of the condition.
- a variety of approaches have been used to reduce the contrast between pigment variation regions, including chemical etches (“peel”), dermabrasion, laser ablation, and UV light sources.
- Prior approaches for dealing with these conditions included removing the abnormally pigmented skin, or a portion of such skin with the goal of promoting new growth that contains cosmetically desirable “natural” pigmentation.
- Another approach provided for treating skin with UV light sources to promote the formation of melanin in melanin-deficient skin.
- UV lamps and excimer laser therapies are examples of some types of UV light sources.
- FIGS. 1A-1B are diagrams showing views of an embodiment of a system herein.
- FIG. 1B shows details of an electric console.
- FIG. 2 is a graph showing the relationship between a minimum melanogensis dose and wavelength.
- FIG. 3 shows an optical power output for an LED array relative to driving current.
- FIG. 4 shows a portion of a selectively controllable LED array.
- FIG. 5 shows a portion of a selectively controllable LED array with photodetectors.
- FIG. 6 shows an LED array coupled with fibers.
- FIG. 7 shows a fiber bundle couple with photodetectors, and different LEDs.
- FIG. 8 is a graph showing a relationship between skin pigmentation and an intensity of back scattered light.
- Generally desirable characteristics of a phototherapeutic approach to pigmentary induction would include: (i) production of a temporary-to-permanent pigmentary darkening in various skin phototypes; and (ii) an ability to target discrete and localized non-uniformities and “blend” them to produce a more uniform pigment background.
- An embodiment herein provides for controlling the exposure to light, so that the treatment does not result in just increasing an overall pigment background by a uniform amount (e.g., merely increasing a base level of all pigment in a treatment area).
- an embodiment herein can provide for a relatively large area UV exposure with some type of masking, or directing a UV point source at a specific local target.
- the system 100 includes a rigid or flexible array module 102 of LEDs 104 arranged such that a high density of LEDs can be achieved.
- the array module 102 is placed in near, or close, contact with the skin, whereby the LEDs 104 are optically coupled with the skin such that light emitted from the LED is incident on the skin being treated.
- the LEDs 104 are electrically configured to allow for low voltage, high current operation.
- the array module 102 is electrically isolated from the patient in case direct contact with the array module 102 occurs. This isolation could be achieved by providing an electrically insulating, but optically transmissive material over the LEDs 104 .
- the array module 102 includes a surface structure 106 to which the LEDs are mounted.
- This surface structure could be formed on a printed circuit board which contains conductive paths from the LEDs 104 to a larger passive heat sink, or active cooler 120 , such as water channel cooled plate.
- Typical heat loading from dissipation by LEDs in such an array is ⁇ 1 W/cm 2 .
- such heat loading can be in the 100's of Watts.
- the console 110 contains a power supply, or driver circuit, 112 capable of providing for pulsed or CW operation of the LEDs 104 , by controlling the electrical energy supplied to the LEDs.
- the console 110 also contains sensing circuits 1 14 to monitor the current, the array temperature, and the light flux. Further as will be discussed in more detail below a processor or controller 116 of the console operates to analyze the information from sensor or detectors in the array module 102 , and to control the amount of current generated to by the driver circuit 112 to drive individual LEDs 104 .
- a user interface 118 is provided to allow a user to control different aspects of the operation. More details related to a general structure of an LED array module and a console used to supply light energy to a patient's skin are disclosed in commonly assigned pending U.S. patent application Ser. No. 10/422,261, entitled SYSTEM AND METHOD FOR TREATING EXPOSED TISSUE WITH LIGHT EMITTING DIODES, filed Apr. 24, 2003, which is incorporated herein by reference in its entirety.
- An embodiment herein provides cosmetically desirable pigmentation in the skin in a spatially and temporally controlled manner.
- Melanin synthesis in melanocytes, or “melanogenesis” refers to this process.
- Melanogenesis can take place as a photoprotective effect in response to UV radiation, and when it occurs in response to natural or artificial UV light, it is referred to as “tanning.”
- IPD intermediate pigment darkening
- the graph shown in FIG. 2 shows the minimum melanogenic dose (MMD) for light skin people along the vertical axis.
- the MMD is on the order of 100 J/cm 2 for 365 nm, 1-10 J/cm 2 for 315 nm, and 0.1 J/cm 2 around 300 nm.
- the MMD is roughly independent of skin phototype. See, e.g., Parrish J A, Jaenicke K F, Anderson R R. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol Vol. 36, pp 187-191, 1982, which is incorporated herein by reference, in its entirety.
- LED performance is best in the visible and infrared, and falls rapidly at the shorter wavelengths of the UVA range.
- Examples of high performance UV LEDs that are commercially available are the NSHU550A and NSHU590A LEDs from Nichia Corporation, Japan. These parts provide 2.0 and 1.4 mW of UVA light centered at 375 nm, respectively. In fact, at present, commercial devices below 360 nm are not readily available. Choosing appropriate LED devices becomes a trade-off between shorter wavelengths, that are more effective, and longer wavelengths at which efficient and practical LED devices can be obtained.
- these arrays provide measured irradiances of up to 200 mW in an approximately 1 cm 2 emitting area.
- the wavelength center of this array was measured to be 395 nm.
- An arrangement of such LED arrays in close proximity to a person's skin can be used to produce a uniformly high irradiance of near-UVA, sub-400 nm illumination field.
- the LEDs provided by Nichia Corporation which can be obtained in 5 mm diameter packages, can be used to produce as much as 5 mW/cm 2 of 375 nm light on skin.
- the approximately 20 ⁇ reduction in irradiance with these LEDs compared to the example above is partially offset by the factor of 3 decrease in the MMD required at this somewhat shorter wavelength, as is illustrated in FIG. 2 .
- FIG. 3 shows the measured output for an OptoTech 395 Shark LED array. At least 200 mW of power at a wavelength of 395 nm is emitted from an array measuring approximately 1 cm 2 , when aggressive cooling of the array substrate is provided. This cooling allows the array to be driven past nominal operation current limits to produce up to several hundred mW of potentially melanogenic radiation.
- Implementation of system 100 with an array module 102 using 395 nm LED arrays should reach the MMD in less than 1 hour of treatment time over a broad treatment area.
- the array module 102 would use approximately 1000 individual LED devices in an array that is designed to treat approximately 50 cm 2 area of the face or back, and drives the entire array at approximately 6 A and 45V, or ⁇ 300 W.
- FIG. 4 shows a cross sectional view of a portion of an array module 402 of a system 400 where spatially controlled UVA is applied to skin.
- This array module 402 in conjunction with the electronic console, which supplies driving electrical current to the array module, would provide spatially addressable direct UVA treatment.
- the LEDs 404 are provided which would be mounted to a printed circuit board (not shown).
- An optically transmissive layer 406 can be positioned adjacent to the emitting area of the LEDs.
- the embodiment shown in FIG. 4 allows one to spatially tailor the exposure or dose in such a way as to create a custom pigmentation induction profile. This is accomplished by making each individual LEDs 404 addressable with continuously adjustable drive current for LED or groups of LEDs. Addressability of each LED requires significantly more traces on the array printed circuit board or substrate to which the LEDs are mounted and could in some implementations reduce the density that LEDs can be placed in the array.
- the delivered irradiance is lower than a system where all of the LEDS are subject to a single control and drive current. This reduction depends on the array size, and can be reduced by addressing entire rows or small blocks or regions of LEDs, rather than individual devices.
- the addressable UVA LED array 402 is positioned so that it is adjacent to the patient's skin 408 which is to be treated.
- the white regions 410 in the skin represent low melanin content in skin.
- the areas 412 and 414 represent irradiance which would be delivered from an LED when current is supplied to the particular LED to drive the device. As shown the darker areas 414 correspond to LEDs which would receive higher current and emit higher energy amounts of UVA to the pigment deficient areas of skin 410 .
- advance knowledge of the desired spatial profile of the treatment dosage or irradiance is required. In operation, an area of the patient's skin which is to be treated would be mapped, and the information would be input to the controller 116 in the electronic console 110 .
- the controller 116 would then cause the driver circuit 112 of the electronic console 110 to output current to regions of LEDS which are positioned to emit UVA to the pigment deficient area of the skin, and other areas which are not pigment deficient would not receive a driving current. It should be noted that depending on the actual implementation each addressable LED region could consist or one or more LEDs.
- the LED array would be such that it is capable of providing very high resolution, so that it can provide UVA to those areas which are pigment deficient.
- pigment deficient areas can be as narrow as 1 mm wide.
- FIG. 5 shows a cross sectional view of a portion of a different embodiment of an array module 502 of a system 500 where spatially controlled UVA is applied to skin.
- the individually addressable array of LEDs is similar to that described above in connection with FIG. 4 , but additionally included are photodetectors.
- FIG. 5 shows the individual LEDs 504 mounted to structure 506 .
- the structure 506 could be printed circuit board or other structure which provides electrical connections to the LEDs.
- photodetectors 508 are shown. These photodetectors 508 are chosen to be sensitive to light backscattered by the skin 510 .
- the LEDs 504 are positioned in near-contact mode such that they are optically coupled with the skin.
- FIG. 8 shows a graph 800 which demonstrates this sensitivity.
- the graph 800 reflects known characteristics of the spectral remittance of skin.
- Lines 802 , 804 , 806 and 808 show the relative intensity of back scattered light different areas of skin pigmentation such as dark mole, dark skin, light mole and light skin respectively.
- skin bearing different pigmented structures exhibits greatly different diffuse reflectance values at various wavelengths. For UV LEDs operating therapeutically below 375 nm, it may be necessary to add some sensing LEDs operating at longer wavelengths.
- the individual photodetectors 508 will sense the amount of light reflected of the skin, and signals corresponding the amount of light received at each of the photodetectors 508 will then be transmitted by electrical connections to the structure 506 , and then via the umbilical chord 108 to the electric console 110 .
- the processor 116 in the electric console 1 10 can then can the correlate the amount of reflected light with an amount of pigment in skin near the detector 508 . Based on the amount of reflected light the controller 116 will then cause the driver circuit to supply an amount of current to LEDs 504 which are in the region associated with the particular photodetector 508 .
- the system 500 as shown in FIG.
- the arrows 512 represent the direction and strength of the light reflected from the low pigment area 516
- the arrows 514 represent the direction and strength of light reflected from higher pigment areas of skin 5 10 .
- more light will be reflected from low areas of pigmentation, and as a result the controller will cause the driver circuit to supply more current to LEDs in these low pigment areas.
- the light from LEDs 504 may serve as the backscattered light that the photodetector 508 senses.
- the lack of pigment causes a higher proportion of the UVA light to be backscattered relative to the more UVA-absorbing pigment bearing regions
- Another embodiment could provide for populating the LED array with a number of alternate wavelength LEDs, where the wavelength of the alternate LEDs could be chosen for maximum contrast in the amount of absorption between pigmented and hypo-pigmented regions (400-550 nm light would be suitable candidate for this purpose—see FIG. 2 )
- the photodetector signals serve as the basis of a control loop for determining the exposure for a given area of skin, and an array of LEDs delivers the appropriate dose profile.
- the feedback or servo mechanism is determined at the beginning of treatment, and is not necessarily dynamic. That is, the initial pigment profile determines the spatial profile of the treatment dosing.
- the photodetector array instead of measuring differences only between initial pigmentation, the photodetector array senses dynamically the changes in remittance due to immediate pigment darkening IPD detection, which can then be used to determine the end point of exposure. This can be done in a spatially localized way, as above, or it can be used to determine the end of the overall treatment.
- FIG. 6 is a view of another embodiment herein.
- an array or arrays LEDS 602 are mounted to a printed circuit board 604 as discussed above.
- a dome lens 606 would then be provided with each of the LEDs 602 .
- a high index ball lens 608 would then be used to couple the light from LED 602 into a corresponding fiber 61 0 .
- a registration plate 612 for the fibers 61 0 can be used to align the fibers 610 with the array of LEDs 602 .
- a cooling element 614 can be mounted adjacent to the printed circuit board for cooling the LEDs 602 , and by providing a temperature conducting path to the LEDs 606 .
- the fibers 610 can then be configured to provide a fiber bundle 616 which could be housed in a hand piece (not shown).
- the array or arrays of LEDs 602 can be located remotely from the skin, and coupled with high efficiency into individual fibers, which are subsequently bundled 616 to produce a broad area high irradiance illumination handpiece or other optical delivery system.
- One advantage is that by concentrating the light into fibers 610 , a larger maximum treatment irradiance can be obtained (generally at the cost of overall efficiency).
- UVA-driven melanogenesis is very strongly dependent on circulatory oxygen. That is, pressing on skin with, say, a window, during phototreatment with a UVA source could drop the response by as much as 10 ⁇ . See, e.g., Auletta M, Gange R W, Tan O T, Matzinger E., Effect of Cutaneous Hypoxia upon erthyma and pigment responses to UVA, UVB and PUVA (8- MOP+UVA ) in Human Skin. J Invest Dermatol 86: 649-652, 1986; which is incorporated herein by reference in its entirety, and discusses the effect of circulatory oxygen on phototreatment.
- FIG. 7 shows an alternative embodiment 700 of the fiber bundle 616 discussed above.
- the fiber bundle 700 provides in for emitting UVA from LEDs in conjunction with using photodetectors which would be located remotely on a printed circuit board and provide for optical sensing.
- the fibers 702 would be coupled to UVA emitting LEDs.
- Some of the fibers 706 are not coupled to LEDs, but rather are connected to photosensors or photodetectors.
- Some fibers 704 may also be connected to a green or other wavelength LED to enhance the sensitivity of the reflectance signal, as discussed above.
- An advantage of the reflectance sensing and treatment fiber bundle 700 is that can provide better spatial resolution than may be achievable with an addressable array.
- the required space between LEDs for printed circuit board traces for each device would no longer place a limit on the density with which emitting devices (output coupled fibers, in this case) can be positioned.
- the position of the detector coupled fibers and the individual LED illuminator fibers would then be mapped, and a controller in the electrical console would determine how much current should be used to drive the individual LEDs or regions of LEDs based on the reflected light received by the fibers which are coupled to the photodetectors.
- Coupling visible LEDs into large core fibers can result in up to 30 % of the light emitted from a domed LED being captured.
- multi-milliWatt LEDs in the 365-375 nm range come available, it will be possible to create bundles using fiber coupling to produce irradiances at the bundle output of tens of milliWatts/cm 2 , sufficient to induce melanogenesis in reasonable treatment times.
- a bundle of fibers or light pipes can be further concentrated, with substantial loss of power, by a secondary guide or reflector.
- Advantages of this approach include the ability to treat small regions by a hand-applied tip, and the use of even higher irradiances than direct arrays or bundled fibers (as much as 100 mW/cm 2 of 365-375 nm may be possible.
Abstract
The invention comprises a system and method for treating an exposed tissue of a patient with a light energy. A plurality of light emitting devices is optically coupled with a patient's tissue, to apply light treatments to the tissue. A driver circuit and a controller operate to drive the light emitting devices to output different intensities of light treatment to different sub-areas of the tissue being treated.
Description
- This patent application is a continuation of U.S. patent application Ser. No. 10/728,527, filed Dec. 5, 2003, which claims the benefit of U.S. Provisional Application No. 60/432,935, filed Dec. 12, 2002, each of which is hereby incorporated herein by reference.
- The present invention provides for spatially selective phototherapy using LEDs.
- A number of diseases, medical or trauma conditions give rise to cosmetically undesirable pigmentary variation in human skin. Scars, temporary or permanent hypo- and hyper-pigmentation, striae (stretch marks), leukoderma, poikiloderma of Civatte, etc., are examples of conditions in which a melanin pigmentation cosmetic defect is presented by at least one component of the condition. A variety of approaches have been used to reduce the contrast between pigment variation regions, including chemical etches (“peel”), dermabrasion, laser ablation, and UV light sources.
- Prior approaches for dealing with these conditions included removing the abnormally pigmented skin, or a portion of such skin with the goal of promoting new growth that contains cosmetically desirable “natural” pigmentation. Another approach provided for treating skin with UV light sources to promote the formation of melanin in melanin-deficient skin.
- Ablative laser skin resurfacing, chemical peels and dermabrasion are examples of some approaches used for removing skin. UV lamps and excimer laser therapies are examples of some types of UV light sources.
- Prior approaches have suffered from a lack of good control over the pigment induction. One shortcoming frequently associated with removing abnormally pigmented skin is that pigment-deficient areas of skin frequently exhibit resistance to melanogenesis or pigment induction. Thus, even after removing a portion of the pigment-deficient area of skin, and generating new growth of skin, the pigment deficiency frequently persists. In connection with providing UV treatment to pigment deficient skin, difficulties are also realized in that the spatial localization of the treatment is difficult to control and results in less than desirable outcomes.
-
FIGS. 1A-1B are diagrams showing views of an embodiment of a system herein.FIG. 1B shows details of an electric console. -
FIG. 2 is a graph showing the relationship between a minimum melanogensis dose and wavelength. -
FIG. 3 shows an optical power output for an LED array relative to driving current. -
FIG. 4 shows a portion of a selectively controllable LED array. -
FIG. 5 .shows a portion of a selectively controllable LED array with photodetectors. -
FIG. 6 shows an LED array coupled with fibers. -
FIG. 7 shows a fiber bundle couple with photodetectors, and different LEDs. -
FIG. 8 is a graph showing a relationship between skin pigmentation and an intensity of back scattered light. - Generally desirable characteristics of a phototherapeutic approach to pigmentary induction would include: (i) production of a temporary-to-permanent pigmentary darkening in various skin phototypes; and (ii) an ability to target discrete and localized non-uniformities and “blend” them to produce a more uniform pigment background. An embodiment herein provides for controlling the exposure to light, so that the treatment does not result in just increasing an overall pigment background by a uniform amount (e.g., merely increasing a base level of all pigment in a treatment area). For example, an embodiment herein can provide for a relatively large area UV exposure with some type of masking, or directing a UV point source at a specific local target.
- A system of an embodiment of the present invention is shown in
FIG. 1A . Thesystem 100 includes a rigid orflexible array module 102 ofLEDs 104 arranged such that a high density of LEDs can be achieved. Thearray module 102 is placed in near, or close, contact with the skin, whereby theLEDs 104 are optically coupled with the skin such that light emitted from the LED is incident on the skin being treated. TheLEDs 104 are electrically configured to allow for low voltage, high current operation. Thearray module 102 is electrically isolated from the patient in case direct contact with thearray module 102 occurs. This isolation could be achieved by providing an electrically insulating, but optically transmissive material over theLEDs 104. - The
array module 102 includes asurface structure 106 to which the LEDs are mounted. This surface structure could be formed on a printed circuit board which contains conductive paths from theLEDs 104 to a larger passive heat sink, oractive cooler 120, such as water channel cooled plate. Typical heat loading from dissipation by LEDs in such an array is <1 W/cm2. For arrays containing 1000 or more LEDs, such heat loading can be in the 100's of Watts. - An
umbilical supply cord 108 containing the driving current lines, temperature sensor, optical sensor and potentially low flow water for active cooling connects thearray module 102 andLEDs 104 with thedrive electronics console 110. Additional details of the console are shown inFIG. 1B . Theconsole 110 contains a power supply, or driver circuit, 112 capable of providing for pulsed or CW operation of theLEDs 104, by controlling the electrical energy supplied to the LEDs. Theconsole 110 also containssensing circuits 1 14 to monitor the current, the array temperature, and the light flux. Further as will be discussed in more detail below a processor orcontroller 116 of the console operates to analyze the information from sensor or detectors in thearray module 102, and to control the amount of current generated to by thedriver circuit 112 to driveindividual LEDs 104. Additionally auser interface 118 is provided to allow a user to control different aspects of the operation. More details related to a general structure of an LED array module and a console used to supply light energy to a patient's skin are disclosed in commonly assigned pending U.S. patent application Ser. No. 10/422,261, entitled SYSTEM AND METHOD FOR TREATING EXPOSED TISSUE WITH LIGHT EMITTING DIODES, filed Apr. 24, 2003, which is incorporated herein by reference in its entirety. - An embodiment herein provides cosmetically desirable pigmentation in the skin in a spatially and temporally controlled manner. Melanin synthesis in melanocytes, or “melanogenesis”, refers to this process. Melanogenesis can take place as a photoprotective effect in response to UV radiation, and when it occurs in response to natural or artificial UV light, it is referred to as “tanning.”
- A distinct phenomenon associated with true melanogenesis also occurs upon exposure to UV and visible light. “Immediate pigment darkening” (IPD) is a transient oxidative change to the state of existing melanin, occurs mostly in darker skin phototypes. The persistence of IPD is hours to days, and is not clinically useful in itself for treating pigmentation cosmetic problems. Strong IPD in dark skin phototypes indicates that longer term (days to onset) melanogenesis will take place, and may serve as a clinical endpoint to pigmentation phototherapy. Additional discussion related to this issue is provided by, Kollias N, Malallah Y H, Al-Ajmi H, Baqer A, Johnson B E, Gonzales S. Erythema and melanogenesis action spectra in heavily pigmented individuals as compared to fair-skinned Caucasians, Photodermatol Photoimmunol Photomedicne 1996: 12: 183-188, which is incorporated herein by reference in its entirety.
- As shown in
FIG. 2 there is a strong dependence between melanogenesis action and wavelength, with the threshold dose rising rapidly as the wavelength increases from the end of the UVB (˜320 nm) into the blue (400 nm). Beyond 400 nm, there is very little melanogenesis. The graph shown inFIG. 2 shows the minimum melanogenic dose (MMD) for light skin people along the vertical axis. The MMD is on the order of 100 J/cm2 for 365 nm, 1-10 J/cm2 for 315 nm, and 0.1 J/cm2 around 300 nm. As has been previously observed, the MMD is roughly independent of skin phototype. See, e.g., Parrish J A, Jaenicke K F, Anderson R R. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol Vol. 36, pp 187-191, 1982, which is incorporated herein by reference, in its entirety. - From a practical standpoint one must recognize that there are some issues that need to be addressed in connection with using LEDs. At present LED performance is best in the visible and infrared, and falls rapidly at the shorter wavelengths of the UVA range. Examples of high performance UV LEDs that are commercially available are the NSHU550A and NSHU590A LEDs from Nichia Corporation, Japan. These parts provide 2.0 and 1.4 mW of UVA light centered at 375 nm, respectively. In fact, at present, commercial devices below 360 nm are not readily available. Choosing appropriate LED devices becomes a trade-off between shorter wavelengths, that are more effective, and longer wavelengths at which efficient and practical LED devices can be obtained.
- Reasonably high flux devices with a central emission band below 400 nm and above 365 nm can be obtained using some currently available LEDs. The MMD's in this band are in the low 100's of J/cm2. For treatments that are reasonably short duration (<1 hr total), and are somewhat above the MMD (for example, 500 J/cm2), irradiances of at least 100 mW/cm2 are desired. Close packed arrays of sub-400 nm devices are commercially available (one example the Shark OTL-395A-5-10-66 available from OptoTech, Inc., Wheeling, Ill.). At distances of a few millimeters, these arrays provide measured irradiances of up to 200 mW in an approximately 1 cm2 emitting area. The wavelength center of this array was measured to be 395 nm. An arrangement of such LED arrays in close proximity to a person's skin can be used to produce a uniformly high irradiance of near-UVA, sub-400 nm illumination field.
- Similarly, the LEDs provided by Nichia Corporation, which can be obtained in 5 mm diameter packages, can be used to produce as much as 5 mW/cm2 of 375 nm light on skin. The approximately 20× reduction in irradiance with these LEDs compared to the example above is partially offset by the factor of 3 decrease in the MMD required at this somewhat shorter wavelength, as is illustrated in
FIG. 2 . - Experiments have been performed using a 410 nm LED arrays to treat a patient's face. While melanogenesis is not expected to occur in this waveband, treatment of a dark phototype skin showed obvious IPD after 30 minutes of treatment at approximately 80 mW/cm2 (140 J/cm2 dose). IPD maximum sensitivity falls between 320 and 380 nm.
-
FIG. 3 shows the measured output for an OptoTech 395 Shark LED array. At least 200 mW of power at a wavelength of 395 nm is emitted from an array measuring approximately 1 cm2, when aggressive cooling of the array substrate is provided. This cooling allows the array to be driven past nominal operation current limits to produce up to several hundred mW of potentially melanogenic radiation. - Implementation of
system 100 with anarray module 102 using 395 nm LED arrays should reach the MMD in less than 1 hour of treatment time over a broad treatment area. In embodiment thearray module 102 would use approximately 1000 individual LED devices in an array that is designed to treat approximately 50 cm2 area of the face or back, and drives the entire array at approximately 6 A and 45V, or ˜300 W. -
FIG. 4 shows a cross sectional view of a portion of anarray module 402 of asystem 400 where spatially controlled UVA is applied to skin. Thisarray module 402 in conjunction with the electronic console, which supplies driving electrical current to the array module, would provide spatially addressable direct UVA treatment. TheLEDs 404 are provided which would be mounted to a printed circuit board (not shown). An opticallytransmissive layer 406 can be positioned adjacent to the emitting area of the LEDs. The embodiment shown inFIG. 4 allows one to spatially tailor the exposure or dose in such a way as to create a custom pigmentation induction profile. This is accomplished by making eachindividual LEDs 404 addressable with continuously adjustable drive current for LED or groups of LEDs. Addressability of each LED requires significantly more traces on the array printed circuit board or substrate to which the LEDs are mounted and could in some implementations reduce the density that LEDs can be placed in the array. - The consequence is that the delivered irradiance is lower than a system where all of the LEDS are subject to a single control and drive current. This reduction depends on the array size, and can be reduced by addressing entire rows or small blocks or regions of LEDs, rather than individual devices.
- The addressable
UVA LED array 402 is positioned so that it is adjacent to the patient'sskin 408 which is to be treated. Thewhite regions 410 in the skin represent low melanin content in skin. Theareas darker areas 414 correspond to LEDs which would receive higher current and emit higher energy amounts of UVA to the pigment deficient areas ofskin 410. In this embodiment, advance knowledge of the desired spatial profile of the treatment dosage or irradiance is required. In operation, an area of the patient's skin which is to be treated would be mapped, and the information would be input to thecontroller 116 in theelectronic console 110. Thecontroller 116 would then cause thedriver circuit 112 of theelectronic console 110 to output current to regions of LEDS which are positioned to emit UVA to the pigment deficient area of the skin, and other areas which are not pigment deficient would not receive a driving current. It should be noted that depending on the actual implementation each addressable LED region could consist or one or more LEDs. - Ideally the LED array would be such that it is capable of providing very high resolution, so that it can provide UVA to those areas which are pigment deficient. In some cases, pigment deficient areas can be as narrow as 1 mm wide.
-
FIG. 5 shows a cross sectional view of a portion of a different embodiment of anarray module 502 of asystem 500 where spatially controlled UVA is applied to skin. In this embodiment, the individually addressable array of LEDs is similar to that described above in connection withFIG. 4 , but additionally included are photodetectors.FIG. 5 shows theindividual LEDs 504 mounted to structure 506. As discussed above thestructure 506 could be printed circuit board or other structure which provides electrical connections to the LEDs. In addition toLEDs 504photodetectors 508 are shown. Thesephotodetectors 508 are chosen to be sensitive to light backscattered by theskin 510. TheLEDs 504 are positioned in near-contact mode such that they are optically coupled with the skin. As is known, different amounts of pigmentation can have a large effect on the spectral remittance (the amount of light backscattered from the skin).FIG. 8 shows agraph 800 which demonstrates this sensitivity. (Thegraph 800 reflects known characteristics of the spectral remittance of skin.)Lines individual photodetectors 508 will sense the amount of light reflected of the skin, and signals corresponding the amount of light received at each of thephotodetectors 508 will then be transmitted by electrical connections to thestructure 506, and then via theumbilical chord 108 to theelectric console 110. Theprocessor 116 in theelectric console 1 10 can then can the correlate the amount of reflected light with an amount of pigment in skin near thedetector 508. Based on the amount of reflected light thecontroller 116 will then cause the driver circuit to supply an amount of current toLEDs 504 which are in the region associated with theparticular photodetector 508. In thesystem 500, as shown inFIG. 5 , thearrows 512 represent the direction and strength of the light reflected from thelow pigment area 516, and thearrows 514 represent the direction and strength of light reflected from higher pigment areas of skin 5 10. As shown, more light will be reflected from low areas of pigmentation, and as a result the controller will cause the driver circuit to supply more current to LEDs in these low pigment areas. - The light from
LEDs 504 may serve as the backscattered light that thephotodetector 508 senses. In this case, the lack of pigment causes a higher proportion of the UVA light to be backscattered relative to the more UVA-absorbing pigment bearing regions Another embodiment could provide for populating the LED array with a number of alternate wavelength LEDs, where the wavelength of the alternate LEDs could be chosen for maximum contrast in the amount of absorption between pigmented and hypo-pigmented regions (400-550 nm light would be suitable candidate for this purpose—seeFIG. 2 ) - In one embodiment the photodetector signals serve as the basis of a control loop for determining the exposure for a given area of skin, and an array of LEDs delivers the appropriate dose profile. In one version, the feedback or servo mechanism is determined at the beginning of treatment, and is not necessarily dynamic. That is, the initial pigment profile determines the spatial profile of the treatment dosing. In still another embodiment, instead of measuring differences only between initial pigmentation, the photodetector array senses dynamically the changes in remittance due to immediate pigment darkening IPD detection, which can then be used to determine the end point of exposure. This can be done in a spatially localized way, as above, or it can be used to determine the end of the overall treatment.
- Further, it is helpful to recognize that the spectral remittance for dark and light human skin is different. Indeed some prior works have specifically compared dark and light skin phototypes, and developed data showing the difference in the relative amount of UVA-visible light which is backscattered. See, e.g., R. R. Anderson and J. A. Parrish, Optical Properties of Human Skin, p. 159-193, The Science of Photomedicine, 1982, which is incorporated herein by reference in its entirety. See also the data shown in
FIG. 8 for diffuse reflectance for different skin pigmentation levels. -
FIG. 6 is a view of another embodiment herein. In this embodiment an array orarrays LEDS 602 are mounted to a printedcircuit board 604 as discussed above. Adome lens 606 would then be provided with each of theLEDs 602. A highindex ball lens 608 would then be used to couple the light fromLED 602 into a corresponding fiber 61 0. Aregistration plate 612 for the fibers 61 0 can be used to align thefibers 610 with the array ofLEDs 602. Acooling element 614 can be mounted adjacent to the printed circuit board for cooling theLEDs 602, and by providing a temperature conducting path to theLEDs 606. Thefibers 610 can then be configured to provide afiber bundle 616 which could be housed in a hand piece (not shown). Additional aspects of coupling light from an LED into a fiber, and related issues are discussed in more detail in commonly assigned pending U.S. patent application Ser. No. 10/171,101, Spooner et al., “Concentration of Divergent Light from Light Emitting Diodes into Therapeutic Light Energy”, filed Jun. 12, 2002, which is incorporated herein by reference in its entirety. - In the
system 600 ofFIG. 6 , the array or arrays ofLEDs 602 can be located remotely from the skin, and coupled with high efficiency into individual fibers, which are subsequently bundled 616 to produce a broad area high irradiance illumination handpiece or other optical delivery system. One advantage is that by concentrating the light intofibers 610, a larger maximum treatment irradiance can be obtained (generally at the cost of overall efficiency). - The
bundle 610 is then placed in near contact with the skin. Actual contact of the bundle or associated delivery against the skin could desirably be minimized. UVA-driven melanogenesis is very strongly dependent on circulatory oxygen. That is, pressing on skin with, say, a window, during phototreatment with a UVA source could drop the response by as much as 10×. See, e.g., Auletta M, Gange R W, Tan O T, Matzinger E., Effect of Cutaneous Hypoxia upon erthyma and pigment responses to UVA, UVB and PUVA (8-MOP+UVA) in Human Skin. J Invest Dermatol 86: 649-652, 1986; which is incorporated herein by reference in its entirety, and discusses the effect of circulatory oxygen on phototreatment. -
FIG. 7 shows analternative embodiment 700 of thefiber bundle 616 discussed above. Thefiber bundle 700 provides in for emitting UVA from LEDs in conjunction with using photodetectors which would be located remotely on a printed circuit board and provide for optical sensing. As shown inFIG. 7 thefibers 702 would be coupled to UVA emitting LEDs. Some of thefibers 706 are not coupled to LEDs, but rather are connected to photosensors or photodetectors. Somefibers 704 may also be connected to a green or other wavelength LED to enhance the sensitivity of the reflectance signal, as discussed above. An advantage of the reflectance sensing andtreatment fiber bundle 700 is that can provide better spatial resolution than may be achievable with an addressable array. The required space between LEDs for printed circuit board traces for each device would no longer place a limit on the density with which emitting devices (output coupled fibers, in this case) can be positioned. In this embodiment the position of the detector coupled fibers and the individual LED illuminator fibers would then be mapped, and a controller in the electrical console would determine how much current should be used to drive the individual LEDs or regions of LEDs based on the reflected light received by the fibers which are coupled to the photodetectors. - Coupling visible LEDs into large core fibers can result in up to 30% of the light emitted from a domed LED being captured. As multi-milliWatt LEDs in the 365-375 nm range come available, it will be possible to create bundles using fiber coupling to produce irradiances at the bundle output of tens of milliWatts/cm2, sufficient to induce melanogenesis in reasonable treatment times.
- An additional advantage of the overall fiber bundle approach is that the light treatment handpiece or delivery system can be small and located far from the actual electronics and light generating array(s).
- Additionally a bundle of fibers or light pipes can be further concentrated, with substantial loss of power, by a secondary guide or reflector. Advantages of this approach include the ability to treat small regions by a hand-applied tip, and the use of even higher irradiances than direct arrays or bundled fibers (as much as 100 mW/cm2 of 365-375 nm may be possible.
- Although specific embodiments and methods of the present invention are shown and described herein, this invention is not to be limited by these methods and embodiments. Rather, the scope of the invention is to be defined by the following claims and their equivalents.
Claims (19)
1. A system for treating a tissue area of a patient with light, wherein the tissue area includes a plurality of sub-areas having different levels of melanin in the different sub-areas, the system comprising:
a plurality of light emitting devices optically coupled with the tissue area, the plurality of light emitting devices configured into different regions that correspond to the different sub-areas having different levels of melanin;
a driver circuit electrically coupled with the plurality of light emitting devices and operable to drive the light emitting devices to output different intensities of light treatment to the different sub-areas; and
a controller coupled to the driver circuit and operable to control the driver circuit to drive the different regions of light emitting devices to output different intensities of light treatment to the different sub-areas based on the different levels of melanin in the different sub-areas.
2. The system of claim 1 , wherein the controller operates to cause the driver circuit to drive a first region of light emitting devices, corresponding to a first sub-area of tissue having a first melanin content, to output a first light treatment, and to drive a second region of light emitting devices, corresponding to a second sub-area having a second melanin content, to output a second light treatment.
3. The system of claim 2 , further including:
a first light sensing device operable to detect light reflected from the first sub-area and generates a first signal corresponding to the reflection of light from the first sub-area, the first light sensing device being coupled to the controller such that the controller receives the first signal and based, on the first signal, causes the driver circuit to drive the first region of light emitting devices to output the first light treatment, which induces tanning in the first sub-area; and
a second light sensing device operable to detect light reflected from the second sub-area and generates a second signal corresponding to the reflection of light from the second sub-area, the second light sensing device being coupled to the controller such that the controller receives the second signal and based, on the second signal, causes the driver circuit to drive the second region of light emitting devices to output the second light treatment, which induces tanning in the second sub-area.
4. The system of claim 1 , wherein the light emitting devices are light emitting diodes.
5. The system of claim 1 , wherein at least one of the different regions of light emitting devices includes only a single light emitting device.
6. The system of claim 1 , wherein at least one of the different regions of light emitting devices includes more than one light emitting device.
7. A system for treating an area of tissue, where the area of tissue includes a plurality of different sub-areas of tissue which have different characteristics, comprising:
a plurality of light emitting devices optically coupled with the area of tissue, the light emitting devices being configured into different regions, that correspond to the different sub-areas of tissue having different characteristics;
a light sensing device operable to sense an amount of light reflected from each of the different sub-areas;
a driver circuit electrically coupled with the plurality of light emitting devices for driving a first region of the plurality of light emitting devices to output a first light treatment to a first sub-area of tissue, wherein the first light treatment is determined based on a first amount of light reflected from the first sub-area, and driving a second region of the plurality of light emitting devices to output a second light treatment to a second sub-area of tissue, wherein the second light treatment is determined based on a second amount of light reflected from the second sub-area of tissue.
8. The system of claim 7 , wherein the first light treatment induces a first amount of tanning in the first sub-area.
9. The system of claim 8 , wherein the second light treatment induces a second amount of tanning in the second sub-area.
10. The system of claim 7 , wherein the first light treatment uses a wavelength below 400 nm.
11. The system of claim 7 , wherein the first light treatment provides for an irradiance at least 100 mW/cm2 for the first sub-area.
12. The system of claim 7 , wherein the first light treatment provides for a first level of irradiance for the first sub-area, and the second light treatment provides for a second level or irradiance for the second sub-area and the second level of irradiance is less that the first level or irradiance.
13. The system of claim 7 , wherein the driver circuit is further operable to drive the plurality of light emitting devices to induce tanning in the area of tissue, such that the, tanning operates to provide for a more uniform distribution pigmentation in the area tissue than was present in the area of tissue prior to the induced tanning.
14. A system for treating an area of tissue, the area of tissue including a plurality of different sub-areas of tissue which have different amounts of pigmentation, comprising:
a light sensing device for sensing an amount of light reflected from each of the plurality of different sub-areas; and
a plurality of light emitting devices optically coupled with the area of tissue, the plurality of light emitting devices operable to apply a light treatment to the area of tissue based on the amount of light reflected from each of the plurality of different sub-areas, wherein the light treatment operates to reduce differences in the amount of pigmentation in different sub-areas of tissue.
15. The system of claim 14 , wherein the plurality of light emitting devices apply the light treatment by generating a first amount of light to apply a first light treatment to a first sub-area of the area of tissue, and generating a second amount of light to apply a second light treatment to a second sub-area of the area of tissue.
16. The system of claim 14 , wherein the plurality of light emitting devices apply a first amount of light energy to a first group of sub-areas of tissue of the area of tissue, where the first group of sub-areas of tissue have less pigmentation than a second group of sub-areas of tissue to which the first amount of light energy is not applied.
17. The system of claim 16 , wherein the first amount of light energy induces a first amount of tanning in the first group of sub-areas of tissue.
18. The system of claim 16 , wherein the first amount of light energy includes light having a wavelength below 400 nm.
19. The system of claim 16 , wherein the first amount of light energy provides for an irradiance at least 100 mW/cm2 for the first group of sub-areas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/272,994 US20060089687A1 (en) | 2002-12-12 | 2005-11-14 | System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43293502P | 2002-12-12 | 2002-12-12 | |
US10/728,527 US6991644B2 (en) | 2002-12-12 | 2003-12-05 | Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
US11/272,994 US20060089687A1 (en) | 2002-12-12 | 2005-11-14 | System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/728,527 Continuation US6991644B2 (en) | 2002-12-12 | 2003-12-05 | Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060089687A1 true US20060089687A1 (en) | 2006-04-27 |
Family
ID=32511680
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/728,527 Expired - Lifetime US6991644B2 (en) | 2002-12-12 | 2003-12-05 | Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
US11/272,994 Abandoned US20060089687A1 (en) | 2002-12-12 | 2005-11-14 | System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/728,527 Expired - Lifetime US6991644B2 (en) | 2002-12-12 | 2003-12-05 | Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs |
Country Status (1)
Country | Link |
---|---|
US (2) | US6991644B2 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070060819A1 (en) * | 2005-09-15 | 2007-03-15 | Palomar Medical Technologies, Inc. | Skin optical characterization device |
US20070239145A1 (en) * | 2006-04-11 | 2007-10-11 | Raphael Laderman | System and method to assist in the treatment of skin conditions |
US20080082090A1 (en) * | 2004-04-01 | 2008-04-03 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
US20100145322A1 (en) * | 2006-12-05 | 2010-06-10 | Roberto Pini | Led device for the haemostasis of blood vessels |
US20100158462A1 (en) * | 2006-03-02 | 2010-06-24 | Bonitatibus Michael H | Sunlight Simulator Apparatus |
US7935107B2 (en) | 1997-05-15 | 2011-05-03 | Palomar Medical Technologies, Inc. | Heads for dermatology treatment |
US7942916B2 (en) | 2002-05-23 | 2011-05-17 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants and topical substances |
US8002768B1 (en) | 1997-05-15 | 2011-08-23 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US8182473B2 (en) | 1999-01-08 | 2012-05-22 | Palomar Medical Technologies | Cooling system for a photocosmetic device |
US8328794B2 (en) | 1996-12-02 | 2012-12-11 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
US8425577B2 (en) | 2010-12-14 | 2013-04-23 | Joanna Vargas | LED phototherapy apparatus |
US8915948B2 (en) | 2002-06-19 | 2014-12-23 | Palomar Medical Technologies, Llc | Method and apparatus for photothermal treatment of tissue at depth |
US9028536B2 (en) | 2006-08-02 | 2015-05-12 | Cynosure, Inc. | Picosecond laser apparatus and methods for its operation and use |
US9780518B2 (en) | 2012-04-18 | 2017-10-03 | Cynosure, Inc. | Picosecond laser apparatus and methods for treating target tissues with same |
US9901746B2 (en) | 2009-07-09 | 2018-02-27 | Koninklijke Philips N.V. | Skin radiation apparatus and method |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
US10245107B2 (en) | 2013-03-15 | 2019-04-02 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
US10335505B2 (en) * | 2017-08-23 | 2019-07-02 | Hepco Holdings, Llc | Sterilization device for incision and wound sites utilizing low intensity UV-C radiation and ozone |
US10434324B2 (en) | 2005-04-22 | 2019-10-08 | Cynosure, Llc | Methods and systems for laser treatment using non-uniform output beam |
US10596282B2 (en) | 2017-08-23 | 2020-03-24 | Hepco Holdings, Llc | Sterilization device utilizing low intensity UV-C radiation and ozone |
US11418000B2 (en) | 2018-02-26 | 2022-08-16 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
US11638836B2 (en) | 2017-08-23 | 2023-05-02 | Hepco Holdings, Llc | Sterilization device utilizing low intensity UV-C radiation and ozone |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060149343A1 (en) * | 1996-12-02 | 2006-07-06 | Palomar Medical Technologies, Inc. | Cooling system for a photocosmetic device |
IL157684A0 (en) * | 2001-03-02 | 2004-03-28 | Palomar Medical Tech Inc | Apparatus and method for photocosmetic and photodermatological treatment |
US20070213792A1 (en) * | 2002-10-07 | 2007-09-13 | Palomar Medical Technologies, Inc. | Treatment Of Tissue Volume With Radiant Energy |
EP1558339A1 (en) * | 2002-10-07 | 2005-08-03 | Palomar Medical Technologies, Inc. | Apparatus for performing photobiostimulation |
AU2003301111A1 (en) * | 2002-12-20 | 2004-07-22 | Palomar Medical Technologies, Inc. | Apparatus for light treatment of acne and other disorders of follicles |
JP2007531544A (en) * | 2003-07-11 | 2007-11-08 | リライアント・テクノロジーズ・インコーポレイテッド | Method and apparatus for fractionated light treatment of skin |
US7282060B2 (en) * | 2003-12-23 | 2007-10-16 | Reliant Technologies, Inc. | Method and apparatus for monitoring and controlling laser-induced tissue treatment |
US20080132886A1 (en) * | 2004-04-09 | 2008-06-05 | Palomar Medical Technologies, Inc. | Use of fractional emr technology on incisions and internal tissues |
EP1748740A4 (en) * | 2004-04-09 | 2008-12-31 | Palomar Medical Tech Inc | Methods and products for producing lattices of emr-treated islets in tissues, and uses therefor |
US7413572B2 (en) * | 2004-06-14 | 2008-08-19 | Reliant Technologies, Inc. | Adaptive control of optical pulses for laser medicine |
US7959656B2 (en) * | 2005-03-02 | 2011-06-14 | Yolo Medical Inc. | Adipose resolve apparatus for low-power laser |
US20060224217A1 (en) * | 2005-04-01 | 2006-10-05 | Medx Health Corp. | Phototherapy device |
BRPI0611186A2 (en) * | 2005-06-03 | 2010-08-24 | Biolase Tech Inc | Tissue treatment device and method |
CN101282692A (en) * | 2005-08-08 | 2008-10-08 | 帕洛玛医疗技术公司 | Eye-safe photocosmetic device |
US20070093798A1 (en) * | 2005-08-29 | 2007-04-26 | Reliant Technologies, Inc. | Method and Apparatus for Monitoring and Controlling Thermally Induced Tissue Treatment |
DE102006008774A1 (en) * | 2006-02-24 | 2007-09-06 | Schikora, Detlef, Dr. | Device for conveying a regenerative tissue process for treating joint arthrosis and complicated fractures and soft tissue damage comprises primary light sources and a holder for holding the light sources |
WO2007106856A2 (en) * | 2006-03-14 | 2007-09-20 | Allux Medical, Inc. | Phototherapy device and method of providing phototherapy to a body surface |
HRP20060149B1 (en) * | 2006-04-19 | 2008-11-30 | Institut "Ruđer Bošković" | Intelligent sequential illuminator photodynamic therapy |
US20080058782A1 (en) * | 2006-08-29 | 2008-03-06 | Reliant Technologies, Inc. | Method and apparatus for monitoring and controlling density of fractional tissue treatments |
US20080161745A1 (en) * | 2006-09-08 | 2008-07-03 | Oliver Stumpp | Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system |
WO2008052189A2 (en) * | 2006-10-26 | 2008-05-02 | Reliant Technologies, Inc. | Micropore delivery of active substances |
WO2008074005A1 (en) * | 2006-12-13 | 2008-06-19 | Palomar Medical Technologies, Inc. | Cosmetic and biomedical applications of ultrasonic energy and methods of generation thereof |
US20080242967A1 (en) * | 2007-03-27 | 2008-10-02 | Ethicon Endo-Surgery, Inc. | Medical imaging and therapy utilizing a scanned beam system operating at multiple wavelengths |
WO2008154000A1 (en) * | 2007-06-08 | 2008-12-18 | Cynosure, Inc. | Thermal surgery safety suite |
US8512386B2 (en) * | 2007-07-24 | 2013-08-20 | Ric Investments, Llc | Infant phototherapy device |
WO2011063252A2 (en) * | 2009-11-19 | 2011-05-26 | Uv Technologies, Llc | Ultraviolet light applicator system and method |
EP2383017A1 (en) * | 2010-04-28 | 2011-11-02 | Koninklijke Philips Electronics N.V. | Phototherapy device |
US10384076B2 (en) * | 2010-08-17 | 2019-08-20 | Koninklijke Philips N.V. | Flexible light therapy device, a plaster and a bandage |
KR20120066286A (en) * | 2010-12-14 | 2012-06-22 | 한국전자통신연구원 | Phototherapy device and method |
US10709600B2 (en) * | 2011-09-20 | 2020-07-14 | The Centre, P.C. | Stretch mark removal device |
US9993658B2 (en) | 2012-08-16 | 2018-06-12 | Yolo Medical Inc. | Light applicators, systems and methods |
EP2996769A1 (en) * | 2013-05-17 | 2016-03-23 | SR LIGHT ApS | Apparatus and method for promoting d-vitamin production in a living organism |
JP2015164511A (en) * | 2014-02-07 | 2015-09-17 | パナソニックIpマネジメント株式会社 | Hair growth inhibition apparatus and hair growth inhibition method |
US9533170B2 (en) | 2014-12-23 | 2017-01-03 | Catherine L. Dye | Multicolor light emitting diode treatment system with uniform illumination |
US9913994B2 (en) * | 2016-02-26 | 2018-03-13 | Steve Marchese | LED therapy bed |
ITUA20162197A1 (en) * | 2016-03-17 | 2017-09-17 | Tommaso Virnicchi | LED LAMP FOR TANNING OR PHOTOTHERAPY |
US10729496B2 (en) | 2017-11-21 | 2020-08-04 | Cutera, Inc. | Dermatological picosecond laser treatment systems and methods using optical parametric oscillator |
US11400308B2 (en) | 2017-11-21 | 2022-08-02 | Cutera, Inc. | Dermatological picosecond laser treatment systems and methods using optical parametric oscillator |
US10864380B1 (en) | 2020-02-29 | 2020-12-15 | Cutera, Inc. | Systems and methods for controlling therapeutic laser pulse duration |
US11253720B2 (en) | 2020-02-29 | 2022-02-22 | Cutera, Inc. | Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing |
CA3177950A1 (en) * | 2020-05-05 | 2021-11-11 | Lumeda Inc. | Time mulitplexed dosimetry system and method |
US20230132952A1 (en) * | 2021-11-03 | 2023-05-04 | Jimmy Youngblood | Photobiomodulation device |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3538919A (en) * | 1967-04-07 | 1970-11-10 | Gregory System Inc | Depilation by means of laser energy |
US3693623A (en) * | 1970-12-25 | 1972-09-26 | Gregory System Inc | Photocoagulation means and method for depilation |
US3834391A (en) * | 1973-01-19 | 1974-09-10 | Block Carol Ltd | Method and apparatus for photoepilation |
US3900034A (en) * | 1974-04-10 | 1975-08-19 | Us Energy | Photochemical stimulation of nerves |
US4122853A (en) * | 1977-03-14 | 1978-10-31 | Spectra-Med | Infrared laser photocautery device |
US4388924A (en) * | 1981-05-21 | 1983-06-21 | Weissman Howard R | Method for laser depilation |
US4461294A (en) * | 1982-01-20 | 1984-07-24 | Baron Neville A | Apparatus and process for recurving the cornea of an eye |
US4608978A (en) * | 1983-09-26 | 1986-09-02 | Carol Block Limited | Method and apparatus for photoepiltion |
US4617926A (en) * | 1982-07-09 | 1986-10-21 | Sutton A Gunilla | Depilation device and method |
US4733660A (en) * | 1984-08-07 | 1988-03-29 | Medical Laser Research And Development Corporation | Laser system for providing target specific energy deposition and damage |
US4819669A (en) * | 1985-03-29 | 1989-04-11 | Politzer Eugene J | Method and apparatus for shaving the beard |
US4829262A (en) * | 1984-10-25 | 1989-05-09 | Candela Laser Corporation | Long pulse tunable light amplifier |
US4917084A (en) * | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US5000752A (en) * | 1985-12-13 | 1991-03-19 | William J. Hoskin | Treatment apparatus and method |
US5057104A (en) * | 1989-05-30 | 1991-10-15 | Cyrus Chess | Method and apparatus for treating cutaneous vascular lesions |
US5059798A (en) * | 1991-05-21 | 1991-10-22 | Siemens Gammasonics, Inc. | Frangible bonding of photomultiplier tubes for use in scintillation cameras and PET scanners |
US5059192A (en) * | 1990-04-24 | 1991-10-22 | Nardo Zaias | Method of hair depilation |
US5178617A (en) * | 1991-07-09 | 1993-01-12 | Laserscope | System for controlled distribution of laser dosage |
US5182857A (en) * | 1989-11-02 | 1993-02-02 | U.S. Philips Corp. | Shaving apparatus |
US5217455A (en) * | 1991-08-12 | 1993-06-08 | Tan Oon T | Laser treatment method for removing pigmentations, lesions, and abnormalities from the skin of a living human |
US5226907A (en) * | 1991-10-29 | 1993-07-13 | Tankovich Nikolai I | Hair removal device and method |
US5304170A (en) * | 1993-03-12 | 1994-04-19 | Green Howard A | Method of laser-induced tissue necrosis in carotenoid-containing skin structures |
US5312395A (en) * | 1990-03-14 | 1994-05-17 | Boston University | Method of treating pigmented lesions using pulsed irradiation |
US5344418A (en) * | 1991-12-12 | 1994-09-06 | Shahriar Ghaffari | Optical system for treatment of vascular lesions |
US5358503A (en) * | 1994-01-25 | 1994-10-25 | Bertwell Dale E | Photo-thermal therapeutic device and method |
US5397327A (en) * | 1993-07-27 | 1995-03-14 | Coherent, Inc. | Surgical laser handpiece for slit incisions |
US5405368A (en) * | 1992-10-20 | 1995-04-11 | Esc Inc. | Method and apparatus for therapeutic electromagnetic treatment |
US5425728A (en) * | 1991-10-29 | 1995-06-20 | Tankovich; Nicolai I. | Hair removal device and method |
US5474549A (en) * | 1991-07-09 | 1995-12-12 | Laserscope | Method and system for scanning a laser beam for controlled distribution of laser dosage |
US5486172A (en) * | 1989-05-30 | 1996-01-23 | Chess; Cyrus | Apparatus for treating cutaneous vascular lesions |
US5500009A (en) * | 1990-11-15 | 1996-03-19 | Amron, Ltd. | Method of treating herpes |
US5505726A (en) * | 1994-03-21 | 1996-04-09 | Dusa Pharmaceuticals, Inc. | Article of manufacture for the photodynamic therapy of dermal lesion |
US5522813A (en) * | 1994-09-23 | 1996-06-04 | Coherent, Inc. | Method of treating veins |
US5527350A (en) * | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
US5531740A (en) * | 1994-09-06 | 1996-07-02 | Rapistan Demag Corporation | Automatic color-activated scanning treatment of dermatological conditions by laser |
US5549660A (en) * | 1990-11-15 | 1996-08-27 | Amron, Ltd. | Method of treating acne |
US5611795A (en) * | 1995-02-03 | 1997-03-18 | Laser Industries, Ltd. | Laser facial rejuvenation |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US5620478A (en) * | 1992-10-20 | 1997-04-15 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5626631A (en) * | 1992-10-20 | 1997-05-06 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5630811A (en) * | 1996-03-25 | 1997-05-20 | Miller; Iain D. | Method and apparatus for hair removal |
US5658323A (en) * | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
US5683380A (en) * | 1995-03-29 | 1997-11-04 | Esc Medical Systems Ltd. | Method and apparatus for depilation using pulsed electromagnetic radiation |
US5735844A (en) * | 1995-02-01 | 1998-04-07 | The General Hospital Corporation | Hair removal using optical pulses |
US5738679A (en) * | 1996-06-26 | 1998-04-14 | S.L.T. Japan Company Limited | Apparatus for laser treatment for living tissue |
US5743901A (en) * | 1996-05-15 | 1998-04-28 | Star Medical Technologies, Inc. | High fluence diode laser device and method for the fabrication and use thereof |
US5743679A (en) * | 1995-08-02 | 1998-04-28 | Dbt Deutsche Bergbau-Technik Gmbh | Hydraulic shield support frame |
US5769787A (en) * | 1984-05-25 | 1998-06-23 | Lemelson; Jerome H. | Medical scanning and treatment system and method |
US5800479A (en) * | 1994-01-20 | 1998-09-01 | Biolight Patent Holding Ab | Device for medical external treatment by means of light |
US5820625A (en) * | 1996-09-26 | 1998-10-13 | Ya-Man Ltd. | Light depilating apparatus |
US5944748A (en) * | 1996-07-25 | 1999-08-31 | Light Medicine, Inc. | Photodynamic therapy apparatus and methods |
US5957960A (en) * | 1997-05-05 | 1999-09-28 | Light Sciences Limited Partnership | Internal two photon excitation device for delivery of PDT to diffuse abnormal cells |
US5964749A (en) * | 1995-09-15 | 1999-10-12 | Esc Medical Systems Ltd. | Method and apparatus for skin rejuvenation and wrinkle smoothing |
US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
US6074382A (en) * | 1997-08-29 | 2000-06-13 | Asah Medico A/S | Apparatus for tissue treatment |
US6080147A (en) * | 1998-06-10 | 2000-06-27 | Tobinick; Edward L. | Method of employing a flashlamp for removal of hair, veins and capillaries |
US6106514A (en) * | 1996-08-12 | 2000-08-22 | O'donnell, Jr.; Francis E. | Laser method for subsurface cutaneous treatment |
US6159236A (en) * | 1999-01-28 | 2000-12-12 | Advanced Photodynamic Technologies, Inc. | Expandable treatment device for photodynamic therapy and method of using same |
US6210425B1 (en) * | 1999-07-08 | 2001-04-03 | Light Sciences Corporation | Combined imaging and PDT delivery system |
US6228075B1 (en) * | 1996-11-07 | 2001-05-08 | Cynosure, Inc. | Alexandrite laser system for hair removal |
US6238425B1 (en) * | 1996-06-07 | 2001-05-29 | Biolight Patent Holding Ab | Device for external medical treatment with monochromatic light |
US6237884B1 (en) * | 1999-06-03 | 2001-05-29 | Stephen E. Howe | Ceiling fan mounting assembly |
US6238424B1 (en) * | 1996-06-07 | 2001-05-29 | Biolight Patent Holding Ab | Device for external treatment with pulsating light of high duty cycle |
US6251127B1 (en) * | 1997-08-25 | 2001-06-26 | Advanced Photodynamic Technologies, Inc. | Dye treatment solution and photodynamic therapy and method of using same |
US6273885B1 (en) * | 1997-08-16 | 2001-08-14 | Cooltouch Corporation | Handheld photoepilation device and method |
US6273884B1 (en) * | 1997-05-15 | 2001-08-14 | Palomar Medical Technologies, Inc. | Method and apparatus for dermatology treatment |
US6290713B1 (en) * | 1999-08-24 | 2001-09-18 | Thomas A. Russell | Flexible illuminators for phototherapy |
US6306130B1 (en) * | 1998-04-07 | 2001-10-23 | The General Hospital Corporation | Apparatus and methods for removing blood vessels |
US6350275B1 (en) * | 1997-06-09 | 2002-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Devices for treating circadian rhythm disorders using LED's |
US20020029071A1 (en) * | 2000-03-23 | 2002-03-07 | Colin Whitehurst | Therapeutic light source and method |
US6383176B1 (en) * | 1999-03-15 | 2002-05-07 | Altus Medical, Inc. | Hair removal device and method |
US6413267B1 (en) * | 1999-08-09 | 2002-07-02 | Theralase, Inc. | Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means |
US20020120312A1 (en) * | 2001-02-27 | 2002-08-29 | Ignatius Ronald W. | Device for the treatment of mucositis |
US6443978B1 (en) * | 1998-04-10 | 2002-09-03 | Board Of Trustees Of The University Of Arkansas | Photomatrix device |
US20020143373A1 (en) * | 2001-01-25 | 2002-10-03 | Courtnage Peter A. | System and method for therapeutic application of energy |
US20030004499A1 (en) * | 2000-01-13 | 2003-01-02 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
US20030009205A1 (en) * | 1997-08-25 | 2003-01-09 | Biel Merrill A. | Treatment device for topical photodynamic therapy and method of using same |
US20030023283A1 (en) * | 1998-11-30 | 2003-01-30 | Mcdaniel David H. | Method and apparatus for the stimulation of hair growth |
US6524329B1 (en) * | 2001-03-08 | 2003-02-25 | Tru-Light Corporation | Body processing using light |
US20030040738A1 (en) * | 2000-06-21 | 2003-02-27 | Ruiz Luis Antonio | Controllable liquid crystal matrix mask particularly suited for performing ophthamological surgery, a laser system with said mask and a method of using the same |
US6537302B1 (en) * | 1999-01-20 | 2003-03-25 | Biolight Patent Holding Ab | Means for external medical treatment by means of light |
US6569155B1 (en) * | 1999-03-15 | 2003-05-27 | Altus Medical, Inc. | Radiation delivery module and dermal tissue treatment method |
US20030117491A1 (en) * | 2001-07-26 | 2003-06-26 | Dov Avni | Apparatus and method for controlling illumination in an in-vivo imaging device |
US6596016B1 (en) * | 1997-03-27 | 2003-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Phototherapy of jaundiced newborns using garments containing semiconductor light-emitting devices |
US20030233138A1 (en) * | 2002-06-12 | 2003-12-18 | Altus Medical, Inc. | Concentration of divergent light from light emitting diodes into therapeutic light energy |
US6676654B1 (en) * | 1997-08-29 | 2004-01-13 | Asah Medico A/S | Apparatus for tissue treatment and having a monitor for display of tissue features |
US20040044384A1 (en) * | 2002-09-03 | 2004-03-04 | Leber Leland C. | Therapeutic method and apparatus |
US20040068305A1 (en) * | 2002-10-07 | 2004-04-08 | Vineet Bansal | Phototherapy system and device |
US20040111132A1 (en) * | 2002-12-10 | 2004-06-10 | Olga Shenderova | Phototherapeutic treatment methods and apparatus |
US20050004631A1 (en) * | 2001-03-08 | 2005-01-06 | Mellen-Thomas Benedict | Light processing of selected body components |
US7311722B2 (en) * | 2001-01-22 | 2007-12-25 | Eric Larsen | Photodynamic stimulation device and methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4178617A (en) * | 1977-01-07 | 1979-12-11 | Black & Decker Inc. | Suppressor-insulator member and circuit arrangement therefor |
US5090798A (en) | 1987-04-27 | 1992-02-25 | Canon Kabushiki Kaisha | Applied intensity distribution controlling apparatus |
US5259380A (en) | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
GB9003097D0 (en) | 1990-02-12 | 1990-04-11 | Scient Generics Ltd | Solid state laser diode light source |
GB9325109D0 (en) | 1993-12-08 | 1994-02-09 | Sls Wales Ltd | Depilation |
US5599342A (en) | 1995-01-27 | 1997-02-04 | Candela Laser Corporation | Method for treating pigmentation abnormalities using pulsed laser radiation with an elongated cross-section and apparatus for providing same |
US6015404A (en) | 1996-12-02 | 2000-01-18 | Palomar Medical Technologies, Inc. | Laser dermatology with feedback control |
-
2003
- 2003-12-05 US US10/728,527 patent/US6991644B2/en not_active Expired - Lifetime
-
2005
- 2005-11-14 US US11/272,994 patent/US20060089687A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3538919A (en) * | 1967-04-07 | 1970-11-10 | Gregory System Inc | Depilation by means of laser energy |
US3693623A (en) * | 1970-12-25 | 1972-09-26 | Gregory System Inc | Photocoagulation means and method for depilation |
US3834391A (en) * | 1973-01-19 | 1974-09-10 | Block Carol Ltd | Method and apparatus for photoepilation |
US3900034A (en) * | 1974-04-10 | 1975-08-19 | Us Energy | Photochemical stimulation of nerves |
US4122853A (en) * | 1977-03-14 | 1978-10-31 | Spectra-Med | Infrared laser photocautery device |
US4388924A (en) * | 1981-05-21 | 1983-06-21 | Weissman Howard R | Method for laser depilation |
US4461294A (en) * | 1982-01-20 | 1984-07-24 | Baron Neville A | Apparatus and process for recurving the cornea of an eye |
US4617926A (en) * | 1982-07-09 | 1986-10-21 | Sutton A Gunilla | Depilation device and method |
US4608978A (en) * | 1983-09-26 | 1986-09-02 | Carol Block Limited | Method and apparatus for photoepiltion |
US5769787A (en) * | 1984-05-25 | 1998-06-23 | Lemelson; Jerome H. | Medical scanning and treatment system and method |
US4733660A (en) * | 1984-08-07 | 1988-03-29 | Medical Laser Research And Development Corporation | Laser system for providing target specific energy deposition and damage |
US4829262A (en) * | 1984-10-25 | 1989-05-09 | Candela Laser Corporation | Long pulse tunable light amplifier |
US4819669A (en) * | 1985-03-29 | 1989-04-11 | Politzer Eugene J | Method and apparatus for shaving the beard |
US4917084A (en) * | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
US5000752A (en) * | 1985-12-13 | 1991-03-19 | William J. Hoskin | Treatment apparatus and method |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US5057104A (en) * | 1989-05-30 | 1991-10-15 | Cyrus Chess | Method and apparatus for treating cutaneous vascular lesions |
US5486172A (en) * | 1989-05-30 | 1996-01-23 | Chess; Cyrus | Apparatus for treating cutaneous vascular lesions |
US5182857A (en) * | 1989-11-02 | 1993-02-02 | U.S. Philips Corp. | Shaving apparatus |
US5312395A (en) * | 1990-03-14 | 1994-05-17 | Boston University | Method of treating pigmented lesions using pulsed irradiation |
US5059192A (en) * | 1990-04-24 | 1991-10-22 | Nardo Zaias | Method of hair depilation |
US5549660A (en) * | 1990-11-15 | 1996-08-27 | Amron, Ltd. | Method of treating acne |
US5500009A (en) * | 1990-11-15 | 1996-03-19 | Amron, Ltd. | Method of treating herpes |
US5059798A (en) * | 1991-05-21 | 1991-10-22 | Siemens Gammasonics, Inc. | Frangible bonding of photomultiplier tubes for use in scintillation cameras and PET scanners |
US5178617A (en) * | 1991-07-09 | 1993-01-12 | Laserscope | System for controlled distribution of laser dosage |
US5474549A (en) * | 1991-07-09 | 1995-12-12 | Laserscope | Method and system for scanning a laser beam for controlled distribution of laser dosage |
US5217455A (en) * | 1991-08-12 | 1993-06-08 | Tan Oon T | Laser treatment method for removing pigmentations, lesions, and abnormalities from the skin of a living human |
US5290273A (en) * | 1991-08-12 | 1994-03-01 | Tan Oon T | Laser treatment method for removing pigement containing lesions from the skin of a living human |
US5425728A (en) * | 1991-10-29 | 1995-06-20 | Tankovich; Nicolai I. | Hair removal device and method |
US5226907A (en) * | 1991-10-29 | 1993-07-13 | Tankovich Nikolai I | Hair removal device and method |
US5344418A (en) * | 1991-12-12 | 1994-09-06 | Shahriar Ghaffari | Optical system for treatment of vascular lesions |
USRE36634E (en) * | 1991-12-12 | 2000-03-28 | Ghaffari; Shahriar | Optical system for treatment of vascular lesions |
US5405368A (en) * | 1992-10-20 | 1995-04-11 | Esc Inc. | Method and apparatus for therapeutic electromagnetic treatment |
US5626631A (en) * | 1992-10-20 | 1997-05-06 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5620478A (en) * | 1992-10-20 | 1997-04-15 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5527350A (en) * | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
US5304170A (en) * | 1993-03-12 | 1994-04-19 | Green Howard A | Method of laser-induced tissue necrosis in carotenoid-containing skin structures |
US5397327A (en) * | 1993-07-27 | 1995-03-14 | Coherent, Inc. | Surgical laser handpiece for slit incisions |
US5800479A (en) * | 1994-01-20 | 1998-09-01 | Biolight Patent Holding Ab | Device for medical external treatment by means of light |
US5358503A (en) * | 1994-01-25 | 1994-10-25 | Bertwell Dale E | Photo-thermal therapeutic device and method |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US5505726A (en) * | 1994-03-21 | 1996-04-09 | Dusa Pharmaceuticals, Inc. | Article of manufacture for the photodynamic therapy of dermal lesion |
US5531740A (en) * | 1994-09-06 | 1996-07-02 | Rapistan Demag Corporation | Automatic color-activated scanning treatment of dermatological conditions by laser |
US5522813A (en) * | 1994-09-23 | 1996-06-04 | Coherent, Inc. | Method of treating veins |
US5735844A (en) * | 1995-02-01 | 1998-04-07 | The General Hospital Corporation | Hair removal using optical pulses |
US5611795A (en) * | 1995-02-03 | 1997-03-18 | Laser Industries, Ltd. | Laser facial rejuvenation |
US5683380A (en) * | 1995-03-29 | 1997-11-04 | Esc Medical Systems Ltd. | Method and apparatus for depilation using pulsed electromagnetic radiation |
US5658323A (en) * | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
US5743679A (en) * | 1995-08-02 | 1998-04-28 | Dbt Deutsche Bergbau-Technik Gmbh | Hydraulic shield support frame |
US5964749A (en) * | 1995-09-15 | 1999-10-12 | Esc Medical Systems Ltd. | Method and apparatus for skin rejuvenation and wrinkle smoothing |
US5630811A (en) * | 1996-03-25 | 1997-05-20 | Miller; Iain D. | Method and apparatus for hair removal |
US5743901A (en) * | 1996-05-15 | 1998-04-28 | Star Medical Technologies, Inc. | High fluence diode laser device and method for the fabrication and use thereof |
US6238424B1 (en) * | 1996-06-07 | 2001-05-29 | Biolight Patent Holding Ab | Device for external treatment with pulsating light of high duty cycle |
US6238425B1 (en) * | 1996-06-07 | 2001-05-29 | Biolight Patent Holding Ab | Device for external medical treatment with monochromatic light |
US5738679A (en) * | 1996-06-26 | 1998-04-14 | S.L.T. Japan Company Limited | Apparatus for laser treatment for living tissue |
US5944748A (en) * | 1996-07-25 | 1999-08-31 | Light Medicine, Inc. | Photodynamic therapy apparatus and methods |
US6106514A (en) * | 1996-08-12 | 2000-08-22 | O'donnell, Jr.; Francis E. | Laser method for subsurface cutaneous treatment |
US5820625A (en) * | 1996-09-26 | 1998-10-13 | Ya-Man Ltd. | Light depilating apparatus |
US6228075B1 (en) * | 1996-11-07 | 2001-05-08 | Cynosure, Inc. | Alexandrite laser system for hair removal |
US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
US6494900B1 (en) * | 1997-01-06 | 2002-12-17 | Norman Salansky | Method for localized low energy photon therapy (LEPT) |
US6596016B1 (en) * | 1997-03-27 | 2003-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Phototherapy of jaundiced newborns using garments containing semiconductor light-emitting devices |
US5957960A (en) * | 1997-05-05 | 1999-09-28 | Light Sciences Limited Partnership | Internal two photon excitation device for delivery of PDT to diffuse abnormal cells |
US6273884B1 (en) * | 1997-05-15 | 2001-08-14 | Palomar Medical Technologies, Inc. | Method and apparatus for dermatology treatment |
US6350275B1 (en) * | 1997-06-09 | 2002-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Devices for treating circadian rhythm disorders using LED's |
US6273885B1 (en) * | 1997-08-16 | 2001-08-14 | Cooltouch Corporation | Handheld photoepilation device and method |
US7070611B2 (en) * | 1997-08-25 | 2006-07-04 | Advanced Photodynamic Technologies, Inc. | Treatment device for topical photodynamic therapy and method of using same |
US6251127B1 (en) * | 1997-08-25 | 2001-06-26 | Advanced Photodynamic Technologies, Inc. | Dye treatment solution and photodynamic therapy and method of using same |
US20030009205A1 (en) * | 1997-08-25 | 2003-01-09 | Biel Merrill A. | Treatment device for topical photodynamic therapy and method of using same |
US6676654B1 (en) * | 1997-08-29 | 2004-01-13 | Asah Medico A/S | Apparatus for tissue treatment and having a monitor for display of tissue features |
US6074382A (en) * | 1997-08-29 | 2000-06-13 | Asah Medico A/S | Apparatus for tissue treatment |
USRE38670E1 (en) * | 1997-08-29 | 2004-12-14 | Asah Medico A/S | Apparatus for tissue treatment |
US6383177B1 (en) * | 1997-08-29 | 2002-05-07 | Asah Medico A/S | Apparatus for tissue treatment |
US6306130B1 (en) * | 1998-04-07 | 2001-10-23 | The General Hospital Corporation | Apparatus and methods for removing blood vessels |
US6443978B1 (en) * | 1998-04-10 | 2002-09-03 | Board Of Trustees Of The University Of Arkansas | Photomatrix device |
US6080147A (en) * | 1998-06-10 | 2000-06-27 | Tobinick; Edward L. | Method of employing a flashlamp for removal of hair, veins and capillaries |
US20030023283A1 (en) * | 1998-11-30 | 2003-01-30 | Mcdaniel David H. | Method and apparatus for the stimulation of hair growth |
US6537302B1 (en) * | 1999-01-20 | 2003-03-25 | Biolight Patent Holding Ab | Means for external medical treatment by means of light |
US6159236A (en) * | 1999-01-28 | 2000-12-12 | Advanced Photodynamic Technologies, Inc. | Expandable treatment device for photodynamic therapy and method of using same |
US6383176B1 (en) * | 1999-03-15 | 2002-05-07 | Altus Medical, Inc. | Hair removal device and method |
US6569155B1 (en) * | 1999-03-15 | 2003-05-27 | Altus Medical, Inc. | Radiation delivery module and dermal tissue treatment method |
US6237884B1 (en) * | 1999-06-03 | 2001-05-29 | Stephen E. Howe | Ceiling fan mounting assembly |
US6210425B1 (en) * | 1999-07-08 | 2001-04-03 | Light Sciences Corporation | Combined imaging and PDT delivery system |
US6413267B1 (en) * | 1999-08-09 | 2002-07-02 | Theralase, Inc. | Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means |
US6290713B1 (en) * | 1999-08-24 | 2001-09-18 | Thomas A. Russell | Flexible illuminators for phototherapy |
US20030004499A1 (en) * | 2000-01-13 | 2003-01-02 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
US20020029071A1 (en) * | 2000-03-23 | 2002-03-07 | Colin Whitehurst | Therapeutic light source and method |
US20030040738A1 (en) * | 2000-06-21 | 2003-02-27 | Ruiz Luis Antonio | Controllable liquid crystal matrix mask particularly suited for performing ophthamological surgery, a laser system with said mask and a method of using the same |
US7311722B2 (en) * | 2001-01-22 | 2007-12-25 | Eric Larsen | Photodynamic stimulation device and methods |
US20020143373A1 (en) * | 2001-01-25 | 2002-10-03 | Courtnage Peter A. | System and method for therapeutic application of energy |
US20020120312A1 (en) * | 2001-02-27 | 2002-08-29 | Ignatius Ronald W. | Device for the treatment of mucositis |
US6524329B1 (en) * | 2001-03-08 | 2003-02-25 | Tru-Light Corporation | Body processing using light |
US20050004631A1 (en) * | 2001-03-08 | 2005-01-06 | Mellen-Thomas Benedict | Light processing of selected body components |
US20030117491A1 (en) * | 2001-07-26 | 2003-06-26 | Dov Avni | Apparatus and method for controlling illumination in an in-vivo imaging device |
US20030233138A1 (en) * | 2002-06-12 | 2003-12-18 | Altus Medical, Inc. | Concentration of divergent light from light emitting diodes into therapeutic light energy |
US20040044384A1 (en) * | 2002-09-03 | 2004-03-04 | Leber Leland C. | Therapeutic method and apparatus |
US6860896B2 (en) * | 2002-09-03 | 2005-03-01 | Jeffrey T. Samson | Therapeutic method and apparatus |
US20040068305A1 (en) * | 2002-10-07 | 2004-04-08 | Vineet Bansal | Phototherapy system and device |
US20040111132A1 (en) * | 2002-12-10 | 2004-06-10 | Olga Shenderova | Phototherapeutic treatment methods and apparatus |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8328794B2 (en) | 1996-12-02 | 2012-12-11 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
US7935107B2 (en) | 1997-05-15 | 2011-05-03 | Palomar Medical Technologies, Inc. | Heads for dermatology treatment |
US8328796B2 (en) | 1997-05-15 | 2012-12-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US8109924B2 (en) | 1997-05-15 | 2012-02-07 | Palomar Medical Technologies, Inc. | Heads for dermatology treatment |
US8002768B1 (en) | 1997-05-15 | 2011-08-23 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US8182473B2 (en) | 1999-01-08 | 2012-05-22 | Palomar Medical Technologies | Cooling system for a photocosmetic device |
US7942915B2 (en) | 2002-05-23 | 2011-05-17 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants |
US7942916B2 (en) | 2002-05-23 | 2011-05-17 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants and topical substances |
US8915948B2 (en) | 2002-06-19 | 2014-12-23 | Palomar Medical Technologies, Llc | Method and apparatus for photothermal treatment of tissue at depth |
US10500413B2 (en) | 2002-06-19 | 2019-12-10 | Palomar Medical Technologies, Llc | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US10556123B2 (en) | 2002-06-19 | 2020-02-11 | Palomar Medical Technologies, Llc | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US20080082090A1 (en) * | 2004-04-01 | 2008-04-03 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
US10434324B2 (en) | 2005-04-22 | 2019-10-08 | Cynosure, Llc | Methods and systems for laser treatment using non-uniform output beam |
US20070060819A1 (en) * | 2005-09-15 | 2007-03-15 | Palomar Medical Technologies, Inc. | Skin optical characterization device |
US8346347B2 (en) | 2005-09-15 | 2013-01-01 | Palomar Medical Technologies, Inc. | Skin optical characterization device |
US20100158462A1 (en) * | 2006-03-02 | 2010-06-24 | Bonitatibus Michael H | Sunlight Simulator Apparatus |
US20070239145A1 (en) * | 2006-04-11 | 2007-10-11 | Raphael Laderman | System and method to assist in the treatment of skin conditions |
US11712299B2 (en) | 2006-08-02 | 2023-08-01 | Cynosure, LLC. | Picosecond laser apparatus and methods for its operation and use |
US9028536B2 (en) | 2006-08-02 | 2015-05-12 | Cynosure, Inc. | Picosecond laser apparatus and methods for its operation and use |
US10966785B2 (en) | 2006-08-02 | 2021-04-06 | Cynosure, Llc | Picosecond laser apparatus and methods for its operation and use |
US10849687B2 (en) | 2006-08-02 | 2020-12-01 | Cynosure, Llc | Picosecond laser apparatus and methods for its operation and use |
US20100145322A1 (en) * | 2006-12-05 | 2010-06-10 | Roberto Pini | Led device for the haemostasis of blood vessels |
US9901746B2 (en) | 2009-07-09 | 2018-02-27 | Koninklijke Philips N.V. | Skin radiation apparatus and method |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
US8425577B2 (en) | 2010-12-14 | 2013-04-23 | Joanna Vargas | LED phototherapy apparatus |
US9780518B2 (en) | 2012-04-18 | 2017-10-03 | Cynosure, Inc. | Picosecond laser apparatus and methods for treating target tissues with same |
US11095087B2 (en) | 2012-04-18 | 2021-08-17 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US10581217B2 (en) | 2012-04-18 | 2020-03-03 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US10305244B2 (en) | 2012-04-18 | 2019-05-28 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US11664637B2 (en) | 2012-04-18 | 2023-05-30 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US10765478B2 (en) | 2013-03-15 | 2020-09-08 | Cynosurce, Llc | Picosecond optical radiation systems and methods of use |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US11446086B2 (en) | 2013-03-15 | 2022-09-20 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US10245107B2 (en) | 2013-03-15 | 2019-04-02 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
US10335505B2 (en) * | 2017-08-23 | 2019-07-02 | Hepco Holdings, Llc | Sterilization device for incision and wound sites utilizing low intensity UV-C radiation and ozone |
US11638836B2 (en) | 2017-08-23 | 2023-05-02 | Hepco Holdings, Llc | Sterilization device utilizing low intensity UV-C radiation and ozone |
US10596282B2 (en) | 2017-08-23 | 2020-03-24 | Hepco Holdings, Llc | Sterilization device utilizing low intensity UV-C radiation and ozone |
US11418000B2 (en) | 2018-02-26 | 2022-08-16 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
US11791603B2 (en) | 2018-02-26 | 2023-10-17 | Cynosure, LLC. | Q-switched cavity dumped sub-nanosecond laser |
Also Published As
Publication number | Publication date |
---|---|
US6991644B2 (en) | 2006-01-31 |
US20040116984A1 (en) | 2004-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6991644B2 (en) | Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs | |
KR102142266B1 (en) | Skin treatment device | |
KR102257415B1 (en) | Hair removal device | |
US20070198004A1 (en) | Photocosmetic device | |
US20050075703A1 (en) | Photodynamic stimulation device and methods | |
KR100670937B1 (en) | Apparatus for receiving beauty treatment of skin using led | |
US20060293727A1 (en) | System and method for treating exposed tissue with light emitting diodes | |
US20040147985A1 (en) | Dermatological treatment flashlamp device and method | |
JPH08505803A (en) | Method and device for performing photoactive therapy | |
KR20090055891A (en) | Led radiator for skin | |
US20090099499A1 (en) | Intelligent sequential illuminating device for photodynamic therapy | |
AU681376B2 (en) | Light emitting diode source for photodynamic therapy | |
CN109310471B (en) | Skin treatment device | |
US20040176824A1 (en) | Method and apparatus for the repigmentation of human skin | |
EP0649667B1 (en) | Quantum energy therapeutic biostimulation apparatus | |
US20220040493A1 (en) | Phototherapy Systems, Methods of Using a Phototherapy System, and Methods of Manufacturing a Phototherapy System | |
Navarrete-de Gálvez et al. | Analysis and evaluation of the operational characteristics of a new photodynamic therapy device | |
CN116943041A (en) | Beauty device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |